Intestinal Anti-Inflammatory Activity of Lentinan: Influence on IL-8 and TNFR1 Expression in Intestinal Epithelial Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Nishitani, Yosuke ^a   Zhang, Ling ^a   Yoshida, Masaru ^b   Azuma, Takeshi ^b   Kanazawa, Kazuki ^a   Hashimoto, Takashi ^a   Mizuno, Masashi ^a  

^a KOBE UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DANSYLCADAVERINE; INTERLEUKIN 8; LENTINAN; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CELL SURFACE; COLITIS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INTESTINE EPITHELIUM CELL; LENTINULA EDODES; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CELL NUCLEUS; COCULTURE TECHNIQUES; COLITIS; COLON; CYTOCHALASIN D; CYTOKINES; ENDOCYTOSIS; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; LENTINAN; LIPOPOLYSACCHARIDES; MICE; PROTEIN TRANSPORT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

LENTINULA EDODES; MUS;

EID: 84876430887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062441     Document Type: Article

References (53)

1. Haller D, Jobin C, (2004) Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr 38: 123-136.
2. Ley RE, Peterson DA, Gordon JI, (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
3. Loftus EV Jr, Sandborn WJ, (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31: 1-20.
4. Bouma G, Strober W, (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-533.
5. Arai F, Takahashi T, Furukawa K, Matsushima K, Asakura H, (1999) Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and Crohn's disease. Dig Dis Sci 43: 2071-2079.
6. Izutani R, Loh EY, Reinecker HC, Ohno Y, Fusunyan RD, et al. (1995) Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells. Inflamm Bowel Dis 1: 37-47.
7. Struyf S, Gouwy M, Dillen C, Proost P, Opdenakker G, et al. (2005) Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue. Eur J Immunol 35: 1583-1591.
8. Zareie M, Singh PK, Irvine EJ, Sherman PM, McKay DM, et al. (2001) Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am J Pathol 158: 1101-1109.
9. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT, (1993) Location of tumour necrosis factor a by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705-1709.
10. Gerard C, Rollins BJ, (2001) Chemokines and disease. Nat Immunol 2: 108-115.
11. Volman JJ, Ramakers JD, Plat J, (2008) Dietary modulation of immune function by beta-glucans. Physiol Behav 94: 276-284.
12. Williams DL, (1997) Overview of (1→3)-beta-d-glucan immunobiology. Med Inflamm 6: 247-250.
13. Tzianabos AO, (2000) Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13: 523-533.
14. Zeković DB, Kwiatkowski S, Vrvić MM, Jakovljević D, Moran CA, (2005) Natural and modified (1→3)-beta-d-glucans in health promotion and disease alleviation. Crit Rev Biotechnol 25: 205-230.
15. Sasaki T, Takasuka N, (1976) Further study of the structure of lentinan, an anti-tumor polysaccharide from Lentinus edodes. Carbohydr Res 47: 99-104.
16. Chihara G, Hamuro J, Maeda YY, Shiio T, Suga T, et al. (1987) Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview. Cancer Detect Prev Suppl 1: 423-443.
17. Wasser SP, (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258-274.
18. Tanoue T, Nishitani Y, Kanazawa K, Hashimoto T, Mizuno M, (2008) In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells. Biochem Biophys Res Commun 374: 565-569.
19. Mizuno M, Minato K, Tsuchida H, (1996) Preparation and specificity of antibodies to an anti-tumor beta-glucan, lentinan. Biochem Mol Biol Int 39: 679-685.
20. Zhang M, Huang J, Xie X, Holman CD, (2009) Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124: 1404-1408.
21. Horiguchi M, Saito A, Sonoda H, (1988) A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy. Gan To Kagaku Ryoho 15: 1973-1977.
22. Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, et al. (2006) Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103: 11276-11281.
23. Kerékgyártó C, Virág L, Tankó L, Chihara G, Fachet J, (1996) Strain differences in the cytotoxic activity and TNF production of murine macrophages stimulated by lentinan. Int J Immunopharmacol 18: 347-353.
24. Zhang L, Li N, Caicedo R, Neu J, (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135: 1752-1756.
25. Gaultier A, Arandjelovic S, Niessen S, Overton CD, Linton MF, et al. (2008) Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood 111: 5316-5325.
26. Noursadeghi M, Tsang J, Haustein T, Miller RF, Chain BM, et al. (2008) Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. J Immunol Methods 329: 194-200.
27. Hase K, Ohshima S, Kawano K, Hashimoto N, Matsumoto K, et al. (2005) Distinct gene expression profiles characterize cellular phenotypes of follicle-associated epithelium and M cells. DNA Res 12: 127-137.
28. Kitajima S, Takuma S, Morimoto M, (1999) Changes in colonic mucosal permeability in mouse in dextran sulfate sodium. Exp Anim 48: 137-143.
29. Mizuno M, Nishitani Y, Hashimoto T, Kanazawa K, (2009) Different suppressive effects of fucoidan and lentinan on IL-8 mRNA expression in in vitro gut inflammation. Biosci Biotechnol Biochem 73: 2324-2325.
30. Li Q, Verma IM, (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
31. Chen G, Goeddel DV, (2002) TNF-R1 signaling: A beautiful pathway. Science 296: 1634-1635.
32. Chen NJ, Chio II, Lin WJ, Duncan G, Chau H, et al. (2008) Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci USA 105: 12429-12434.
33. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, et al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561.
34. Schütze S, Tchikov V, Schneider-Brachert W, (2008) Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 9: 655-662.
35. Salisbury JL, Condeelis JS, Satir P, (1980) Role of coated vesicles, microfilaments, and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid cells. J Cell Biol 87: 132-141.
36. Wang LH, Rothberg KG, Anderson RG, (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123: 1107-1117.
37. Hibi T, Inoue N, Ogata H, Naganuma M, (2003) Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J Gastroenterol 38: 36-42.
38. Bent S, Ko R, (2004) Commonly used herbal medicines in the United States: a review. Am J Med 116: 478-485.
39. Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, et al. (2006) Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen presenting cells and immunological tolerance. J Clin Invest 116: 916-928.
40. Rolandeli RH, Saul SH, Settle RG, Jacobs DO, Trerotola SO, et al. (1988) Comparison of parenteral nutrition and enteral feeding with pectin in experimental colitis in the rat. Am J Clin Nutr 47: 715-721.
41. Lim BO, Lee SH, Park DK, Choue RW, (2003) Effect of dietary pectin on the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci Biotechnol Biochem 67: 1706-1712.
42. Liu L, Wang ZP, Xu CT, Pan BR, Mei QB, et al. (2003) Effect of Rheum tanguticum polysaccharide on TNBS-induced colitis and CD4+ T cells in rats. World J Gastroenterol 9: 2284-2288.
43. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S, (1992) Cytokine production in patients with inflammatory bowel disease. Gut 33: 933-937.
44. O'Shea JJ, Ma A, Lipsky P, (2002) Cytokines and autoimmunity. Nat Rev Immunol 2: 37-45.
45. Pullman WE, Elsbury S, Kobayashi M, Hapel AJ, Doe WF, (1992) Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102: 529-537.
46. Akira S, Hirano T, Taga T, Kishimoto T, (1990) Biology of multifunctional cytokines: IL-6 and related molecules (IL 1 and TNF). FASEB J 4: 2860-2867.
47. Al-Sadi R, Ye D, Dokladny K, Ma TY, (2008) Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability. Immunology 180: 5653-5661.
48. Rahman I, Gilmour PS, Jimenez LA, Biswas SK, Antonicelli F, et al. (2003) Ergothioneine inhibits oxidativestress- and TNF-alpha-induced NF-kappaB activation and interleukin-8 release in alveolar epithelial cells. Biochem Biophys Res Commun 302: 860-864.
49. Zhu YM, Bradbury DA, Pang L, Knox AJ, (2003) Transcriptional regulation of interleukin (IL)-8 by bradykinin inhuman airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoidindependent activation of NF-kappaB. J Biol Chem 278: 29366-29375.
50. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K, (1994) Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56: 554-558.
51. McElroy SJ, Frey MR, Yan F, Edelblum KL, Goettel JA, et al. (2008) Tumor necrosis factor inhibits ligand-stimulated EGF receptor activation through a TNF receptor 1-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 295: G285-293.
52. Chin YR, Horwitz MS, (2006) Adenovirus RID complex enhances degradation of internalized tumour necrosis factor receptor 1 without affecting its rate of endocytosis. J Gen Virol 87: 3161-3167.
53. Chin YR, Horwitz MS, (2005) Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDα/β complex. J Virol 79: 13606-13617.